ENTITY
SMARTSCORE: 2.4/5
Bloomage Biotechnology  Lt

Bloomage Biotechnology Lt (688363 CH)

77
Analysis
Health CareChina
Bloomage Biotechnology Corporation Limited develops and manufactures medical products. The Company produces fillers, mesotherapy products, bio reactive hyaluronic acids, repair soothing skin care products, and other products. Bloomage Biotechnology supplies its products in medicine, cosmetics, food manufacturing companies, medical institutions, and other fields.
more
29 May 2021 10:52

CSI300 Index Rebalance: 25 Changes as Long/Short Trade Does Well

There are 25 changes to the CSI300 Index that will be implemented at the close on 11 June. One-way turnover is 3.67% and the adds have outperformed...

Logo
567 Views
Share
22 Apr 2021 01:10

Bloomage Biotechnology (688363.CH) - Opportunities Coexist with Challenges

This article mainly analyzed Bloomage Biotechnology in terms of the logic behind entering the functional food market, the rally of stock price, the...

Logo
493 Views
Share
13 Apr 2021 23:28

CSI300 Index Rebalance Preview: Recovering from the Growth Sell-Off

We forecast 30 changes to the CSI300 Index at the June review that will be announced at the end of May and effective 11 June. The expected...

Logo
502 Views
Share
16 Feb 2021 02:11

EM Remains Global Leadership -- Remain Overweight

Price and RS uptrends for the MSCI EM index continues to underpin our bullish outlook for emerging market equities -- remain overweight.

Logo
255 Views
Share
16 Feb 2021 00:58

CSI300 Index Rebalance Preview: Maxing Out the Number of Changes

We see 30 potential inclusions/exclusions to the CSI300 index at the June review that will become effective COB 11 June. With a lot of benchmarked...

Logo
697 Views
Share
x